{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:08:36Z","timestamp":1780621716865,"version":"3.54.1"},"reference-count":15,"publisher":"Walter de Gruyter GmbH","issue":"5","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2705302"],"award-info":[{"award-number":["2022YFC2705302"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270837"],"award-info":[{"award-number":["82270837"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpem-2026-0063_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Aromatase inhibitors (AIs) are widely used in clinical practice, including for the treatment of adolescents with short stature. However, their potential impact on the long-term reproductive function of male adolescents remains unclear. This exploratory study aimed to investigate this relationship.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2026-0063_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We identified male patients with short stature who had completed AI therapy between 2015 and 2022 at the First Affiliated Hospital of Zhejiang University School of Medicine. A follow-up study was conducted in 2023 to assess semen parameters and retrospectively collect data on sex hormone levels and complications during the treatment period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2026-0063_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ten patients met the inclusion criteria and consented to participate. Of these, nine provided both semen and blood samples, while one provided only a blood sample. The median treatment duration was 1.93\u00a0years (range: 1.0\u20133.5 years), and the median age at treatment initiation was 12.7\u00a0years (range: 11\u201316 years). The median sperm concentration was 78.99 million\/mL (range: 16.93\u2013223.88 million\/mL). The median acrosome integrity was 75.71\u202f% (range: 30.9\u201393.4\u202f%), and the median DNA fragmentation index (DFI) was 15.39\u202f% (range: 8.62\u201325.72\u202f%). Sex hormone levels for all patients were within normal ranges at follow-up, and the majority exhibited normal semen analysis results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2026-0063_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this case series study, the administration of aromatase inhibitors during adolescence was not associated with adverse effects on reproductive function parameters in early adulthood. These preliminary findings do not raise concerns regarding long-term reproductive safety. But larger, prospective studies are warranted for confirmation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpem-2026-0063","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T09:48:42Z","timestamp":1776160122000},"page":"457-463","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of male reproductive function after aromatase inhibitor treatment during adolescence: case series with literature review"],"prefix":"10.1515","volume":"39","author":[{"given":"Chengjun","family":"Dai","sequence":"first","affiliation":[{"name":"Department of Pediatrics, The First Affiliated Hospital, College of Medicine , Zhejiang University , Hangzhou , Zhejiang Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingchao","family":"Ding","sequence":"additional","affiliation":[{"name":"College of Medicine , Zhejiang University , Hangzhou , Zhejiang Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junrong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zhejiang Provincial Center for Maternal, Child and Reproductive Health , Hangzhou , Zhejiang Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The First Affiliated Hospital, College of Medicine , Zhejiang University , Hangzhou , Zhejiang Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlan","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The First Affiliated Hospital, College of Medicine , Zhejiang University , Hangzhou , Zhejiang Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The First Affiliated Hospital, College of Medicine , Zhejiang University , Hangzhou , Zhejiang Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"2026060500564536239_j_jpem-2026-0063_ref_001","doi-asserted-by":"crossref","unstructured":"Hero, M, Norjavaara, E, Dunkel, L. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial. J\u00a0Clin Endocrinol Metabol 2005;90:6396\u2013402. https:\/\/doi.org\/10.1210\/jc.2005-1392.","DOI":"10.1210\/jc.2005-1392"},{"key":"2026060500564536239_j_jpem-2026-0063_ref_002","doi-asserted-by":"crossref","unstructured":"Mauras, N, Gonzalez de Pijem, L, Hsiang, HY, Desrosiers, P, Rapaport, R, Schwartz, ID, et al.. Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial\u00a0for\u00a0one to three years. J\u00a0Clin Endocrinol Metabol 2008;93:823\u201331. https:\/\/doi.org\/10.1210\/jc.2007-1559.","DOI":"10.1210\/jc.2007-1559"},{"key":"2026060500564536239_j_jpem-2026-0063_ref_003","doi-asserted-by":"crossref","unstructured":"Salehpour, S, Alipour, P, Razzaghy-Azar, M, Ardeshirpour, L, Shamshiri, A, Monfared, MF, et al.. A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature. Hormone Res Paediatr 2010;74:428\u201335. https:\/\/doi.org\/10.1159\/000315482.","DOI":"10.1159\/000315482"},{"key":"2026060500564536239_j_jpem-2026-0063_ref_004","doi-asserted-by":"crossref","unstructured":"Varimo, T, Huopio, H, Kariola, L, Tenhola, S, Voutilainen, R, Toppari, J, et al.. Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty: a randomised controlled phase 3 trial. Lancet Child Adolesc Health 2019;3:109\u201320. https:\/\/doi.org\/10.1016\/S2352-4642(18)30377-8.","DOI":"10.1016\/S2352-4642(18)30377-8"},{"key":"2026060500564536239_j_jpem-2026-0063_ref_005","doi-asserted-by":"crossref","unstructured":"Hero, M, Toiviainen-Salo, S, Wickman, S, M\u00e4kitie, O, Dunkel, L. Vertebral morphology in aromatase inhibitor-treated males with idiopathic short stature or constitutional delay of puberty. J\u00a0Bone Miner Res: Off J Am Soc Bone Mineral Res 2010;25:1536\u201343. https:\/\/doi.org\/10.1002\/jbmr.56.","DOI":"10.1002\/jbmr.56"},{"key":"2026060500564536239_j_jpem-2026-0063_ref_006","doi-asserted-by":"crossref","unstructured":"Shulman, DI, Francis, GL, Palmert, MR, Eugster, EA. Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development. Pediatrics 2008;121:e975\u201383. https:\/\/doi.org\/10.1542\/peds.2007-2081.","DOI":"10.1542\/peds.2007-2081"},{"key":"2026060500564536239_j_jpem-2026-0063_ref_007","doi-asserted-by":"crossref","unstructured":"Leschek, EW, Flor, AC, Bryant, JC, Jones, JV, Barnes, KM, Cutler, GBJr. Effect of antiandrogen, aromatase inhibitor, and Gonadotropin-releasing hormone analog on adult height in familial Male precocious puberty. J\u00a0Pediatr 2017;190:229\u201335. https:\/\/doi.org\/10.1016\/j.jpeds.2017.07.047.","DOI":"10.1016\/j.jpeds.2017.07.047"},{"key":"2026060500564536239_j_jpem-2026-0063_ref_008","doi-asserted-by":"crossref","unstructured":"Kohva, E, Varimo, T, Huopio, H, Tenhola, S, Voutilainen, R, Toppari, J, et al.. Anti-M\u00fcllerian hormone and letrozole levels in boys with constitutional delay of growth and puberty treated with letrozole or testosterone. Hum Reprod 2020;35:257\u201364. https:\/\/doi.org\/10.1093\/humrep\/dez231.","DOI":"10.1093\/humrep\/dez231"},{"key":"2026060500564536239_j_jpem-2026-0063_ref_009","doi-asserted-by":"crossref","unstructured":"Sansone, A, Kliesch, S, Isidori, AM, Schlatt, S. AMH and INSL3 in testicular and extragonadal pathophysiology: what do we know? Andrology 2019;7:131\u20138. https:\/\/doi.org\/10.1111\/andr.12597.","DOI":"10.1111\/andr.12597"},{"key":"2026060500564536239_j_jpem-2026-0063_ref_010","doi-asserted-by":"crossref","unstructured":"Mauras, N, Bell, J, Snow, BG, Winslow, KLJF, Sterility. Sperm analysis in growth hormone-deficient adolescents previously treated with an aromatase inhibitor: Comparison with normal controls. Fertil Steril 2005;84:239\u201342. https:\/\/doi.org\/10.1016\/j.fertnstert.2005.02.012.","DOI":"10.1016\/j.fertnstert.2005.02.012"},{"key":"2026060500564536239_j_jpem-2026-0063_ref_011","doi-asserted-by":"crossref","unstructured":"Shuling, L, Kuei, MS, Saffari, SE, Jiayun, Z, Yeun, T, Leng, J, et al.. Do men with normal testosterone\u2013oestradiol ratios benefit from letrozole for the treatment of male infertility? Reprod Biomed Online 2018;38.","DOI":"10.1016\/j.rbmo.2018.09.016"},{"key":"2026060500564536239_j_jpem-2026-0063_ref_012","doi-asserted-by":"crossref","unstructured":"Kooshesh, L, Bahmanpour, S, Zeighami, S, Nasr-Esfahani, MHJRB, RBE, E. Effect of Letrozole on sperm parameters, chromatin status and ROS level in idiopathic Oligo\/Astheno\/Teratozoospermia. Reprod Biol Endocrinol 2020;18. https:\/\/doi.org\/10.1186\/s12958-020-00591-2.","DOI":"10.1186\/s12958-020-00591-2"},{"key":"2026060500564536239_j_jpem-2026-0063_ref_013","doi-asserted-by":"crossref","unstructured":"Maffei, L, Rochira, V, Zirilli, L, Antunez, P, Aranda, C, Fabre, B, et al.. A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome. Clin Endocrinol 2007;67:218\u201324. https:\/\/doi.org\/10.1111\/j.1365-2265.2007.02864.x.","DOI":"10.1111\/j.1365-2265.2007.02864.x"},{"key":"2026060500564536239_j_jpem-2026-0063_ref_014","doi-asserted-by":"crossref","unstructured":"Lanfranco, F, Zirilli, L, Baldi, M, Pignatti, E, Corneli, G, Ghigo, E, et al.. A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment. Bone 2008;43:628\u201335. https:\/\/doi.org\/10.1016\/j.bone.2008.05.011.","DOI":"10.1016\/j.bone.2008.05.011"},{"key":"2026060500564536239_j_jpem-2026-0063_ref_015","doi-asserted-by":"crossref","unstructured":"Mauras, N, Ross, J, Mericq, V. Management of growth disorders in puberty: GH, GnRHa, and aromatase inhibitors: a clinical review. Endocr Rev 2023;44:1\u201313. https:\/\/doi.org\/10.1210\/endrev\/bnac014.","DOI":"10.1210\/endrev\/bnac014"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2026-0063\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2026-0063\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:57:08Z","timestamp":1780621028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2026-0063\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3,16]]},"published-print":{"date-parts":[[2026,5,26]]}},"alternative-id":["10.1515\/jpem-2026-0063"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2026-0063","relation":{},"ISSN":["0334-018X","2191-0251"],"issn-type":[{"value":"0334-018X","type":"print"},{"value":"2191-0251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]}}}